Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Mepivacaine Dose Versus Volume on Axillary Brachial Plexus Block Duration
2012-001704-38Phase 4Completed
- Sponsor
- Sint Maartenskliniek
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mepivacaine (2 arms), sponsored by Sint Maartenskliniek. Primary endpoints: Duration of sensory axillary brachial plexus block (overall) and Duration of sensory block for individual nerves. Started May 2012; status: completed.
02
Drugs
mepivacaine
Beyond the preview
Go deeper on 2012-001704-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001704-38.